Suboptimal Use of SGLT2 Inhibitors in Individuals With Diabetes and Heart Failure
A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.
All articles by Endocrinology Advisor Contributing Writer
Suboptimal Use of SGLT2 Inhibitors in Individuals With Diabetes and Heart Failure
A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.
HbA1c May Predict Outcome in Patients With Type 2 Diabetes Admitted for Acute Stroke
A team of investigators sought to identify the impact of hyperglycemia on the severity of and outcomes associated with stroke in patients with type 2 diabetes.
Bone Turnover Lower Among Men With Type 2 Diabetes Mellitus, A1c Greater Than 7%
Study authors identified whether the hemoglobin A1c threshold level where reduction in bone turnover begins.
Ertugliflozin Plus Insulin Improves Body Weight, HbA1c, and More for T2DM
Researchers sought to determine whether ertugliflozin plus insulin would help redice body weight, systolic blood pressure, HbA1c, and other metrics among individuals with T2DM.
RAAS Antagonism Reduces COVID-19 Severity in Obesity-Related Hypertension
Researchers investigated the effects of RAAS antagonism on the severity of COVID-19 in patients with obesity-related hypertension.
Weight Loss Maintenance Important for Cardiometabolic Risk Control in T2D
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...